Deirdre Connelly ’83 will take the helm as president and CEO of Human Genome Sciences following the company’s acquisition by GlaxoSmithKline, one of the world’s leading research-based pharmaceutical and healthcare companies.
HGS, headquartered in Rockville, Md., exists to place new therapies into the hands of those battling serious diseases.